|
1.
|
|
Effects of anti-hypertensive treatment on graft function and proteinuria in a kidney transplant from an elderly hypertensive donor 2008/01
|
|
2.
|
|
Middle molecular uremic substances retention itself might influence the bioincompatibility of PD solution. 2008/01
|
|
3.
|
|
Obesity-related nephropathy associated with a history of IgA nephropathy. 2008/01
|
|
4.
|
|
Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan. 2008/03
|
|
5.
|
|
Osteoprotegerin affects the responsivenss of FGF-23 to high oral phosphate intake. 2008/04
|
|
6.
|
|
A case of glomerulopathy showing podocytic infolding in association with Sjögren's syndrome and primary biliary cirrhosis. 2008/06
|
|
7.
|
|
Effects of anti-hypertensive treatment on graft function and proteinuria in a kidney transplant from an elderly hypertensive donor. 2008/07
|
|
8.
|
|
T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. 2008/07
|
|
9.
|
|
Hypereosinophilia associated with increased serum levels of carcinoembryonic antigen. 2008/10
|
|
10.
|
|
Uricosuric action of losartan via the inhibitation of urate transporter 1(URAT1) in Hypertensive. 2008/10
|
|
11.
|
|
Uricosuric action of losartan via the inhibitation of urate transporter 1(URAT1) in Hypertensive. 2008/10
|
|
12.
|
|
A case report of glomerulopathy-associated podocyte infolding in a patient with tumor lysis syndrome. 2008/12
|
|
13.
|
|
Insulin resistance is a risk factor for the progression of chronic renal failure. 2009/01
|
|
14.
|
|
Regression of parathyroid gland swelling by treatment with cinacalcet. 2009/01
|
|
15.
|
|
Antiproteinuric effect of olmesartan in patients with IgA nephropathy. 2009/02
|
|
16.
|
|
Antiproteinuric effect of olmesartan in patients with IgA nephropathy. 2009/03
|
|
17.
|
|
Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy. 2009/03
|
|
18.
|
|
Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients. 2009/03
|
|
19.
|
|
Dihydropyridine- and voltage-sensitive Ca2+ entry in human parathyroid cells. 2009/07
|
|
20.
|
|
A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplatation 2009/08
|
|
21.
|
|
Sodium-sensitive variability of the antiproteinuric efficacy of RAS inhibitiors in outpatients with IgA nephropathy. 2009/10
|
|
22.
|
|
Dialysis in pandemic influenza. 2009/11
|
|
23.
|
|
Prescribing peritoneal dialysis in each patient with uremic toxins as the treatment marker. 2009/12
|
|
24.
|
|
Successful effect of triple blockade of renin angiotensin aldosterone system on massive proteinuria in a patiemts with chronic kidney disease. 2009/12
|
|
25.
|
|
Effect of fenofibrate on uric acid metabolism and urate transporter 1. 2010/01
|
|
26.
|
|
Effect of fenofibrate on uric acid metabolism and urate transporter 1. 2010/01
|
|
27.
|
|
Effect of fenofibrate on uric acid metabolism and urate transporter 1. 2010/01
|
|
28.
|
|
Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy. 2010/01
|
|
29.
|
|
Rapidly progressive cryoglobulinemic glomerulonephritis. 2010/01/07
|
|
30.
|
|
Persistent alpha-Klotho (a-Kl) expression in theparathyroid glands of patients with secondary hyperparathyroidism. 2010/03
|
|
31.
|
|
Persistent alpha-Klotho(a-Kl) expression in the papathyroid glands of patients with secondary hyperparathyroidism. 2010/03
|
|
32.
|
|
A strategy for encapsulating peritoneal sclerosis: pay attention not only to PD solution but also middle molecular uraemic substances retention! 2010/04
|
|
33.
|
|
Anxiety for the influenza of the patient with dialysis: choice of the HD/PD combination therapy. 2010/04
|
|
34.
|
|
Anxiety for the influenza of the patient with dialysis: choice of the HD/PD combination therapy. 2010/04
|
|
35.
|
|
The hypothesis that bone turnover influenced FGF23 secretion 2010/04
|
|
36.
|
|
The hypothesis that bone turnover influenced FGF23 secretion 2010/04
|
|
37.
|
|
L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms. 2010/04/28
|
|
38.
|
|
Should the targeted value of the phosphate be reviewed in the normal range from the viewpoint of vascular calcification? 2010/05
|
|
39.
|
|
Establishment and analysis of SLC22A12 (URAT1) knockout mouse. 2010/06
|
|
40.
|
|
Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation 2010/07
|
|
41.
|
|
A thermoreversible polymer mediates controlled release of GDNF to enhance kidney regeneration. 2010/08
|
|
42.
|
|
Activation of the transcription factor c-Jun in acute cellular and antibody-mediated rejection after kidney transplantation 2010/08/04
|
|
43.
|
|
Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method. 2010/08/15
|
|
44.
|
|
Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. 2010/09
|
|
45.
|
|
The redox state of albumin and serious cardiovascular incidence in hemodialysis patients. 2010/10
|
|
46.
|
|
Medullary ray injury in renal allografts 2010/10/06
|
|
47.
|
|
Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a apatient on peritoneal dialysis 2010/10/20
|
|
48.
|
|
Effects of probenecid on the pharmacokinetics of mizoribine and co-administration of the two drugs in patients with nephrotic syndrome. 2010/11
|
|
49.
|
|
The hypothesis that abnormal BH? metabolism impairs kidney function. 2010/11
|
|
50.
|
|
Peritoneal clearance and transport of methylglyoxal. 2010/11/19
|
|
51.
|
|
A case of slowly progressive scleroderma kidney. 2011/01
|
|
52.
|
|
Difference in coronary artery intima and media calcification in autopsied patients with chronic kidney disease 2011/01
|
|
53.
|
|
Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients. 2011/01
|
|
54.
|
|
Decrease in reduced-form albumin among chronic kidney disease patients: New insights in cardiovascular complications. 2011/01/25
|
|
55.
|
|
A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate 2011/01/70
|
|
56.
|
|
A case of slowly progressive scleroderma kidney. 2011/02
|
|
57.
|
|
Augmented antihypertensive effect of a fixed dose combination formula of candesartan and hydlochlorthiazide in a patien on peritoneal dialysis 2011/02
|
|
58.
|
|
A reported oral administration study of febuxostat (TMX-67), a nonpurine selective inhibitor of xanthine oxidase, in patients with impaired renal function in japan. 2011/06
|
|
59.
|
|
et al. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate. 2011/06
|
|
60.
|
|
Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study. 2011/07
|
|
61.
|
|
Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study. 2011/07
|
|
62.
|
|
Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation. 2011/07
|
|
63.
|
|
Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation. 2011/07
|
|
64.
|
|
Two cases of nephrotic syndrome (NS)-induced acute kidney injury (AKI) associated renal hypouricemia. 2011/07
|
|
65.
|
|
Two cases of nephrotic syndrome (NS)-induced acute kidney injury (AKI) associated with renal hypouricemia. 2011/07
|
|
66.
|
|
Two cases of nephrotic syndrome (NS)-induced acute kidney injury (AKI) associtated with renal hypouricemia. 2011/07
|
|
67.
|
|
Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study. 2011/11
|
|
68.
|
|
Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults. 2011/11
|
|
69.
|
|
Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy. 2011/11
|
|
70.
|
|
ABCG2/BCRP dysfunction as a major cause of gout. 2011/12
|
|
71.
|
|
Diagnostic tests for primary renal hypouricemia. 2011/12
|
|
72.
|
|
Discordant clinicopathological features in monozygotic twins with IgA nephropathy. 2011/12
|
|
73.
|
|
Identification of ABCG2 dysfunction as a major factor contributing to gout. 2011/12
|
|
74.
|
|
Functional development of a transplanted embryonic kidney: effect of transplantation site. 2012/01
|
|
75.
|
|
Successful treatment of adult IgA nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine 2012/01
|
|
76.
|
|
Guidelines and medication compliance. 2012/03
|
|
77.
|
|
Metanephros Transplantation Inhibits the Progression of Vascular Calcification in Rats with Adenine-Induced Renal Failure 2012/03
|
|
78.
|
|
The long-term antiproteinuric effect of eplerenone, a selective aldosterone blocker, in patients with non-diabetic chronic kidney disease. 2012/03
|
|
79.
|
|
A case of idiopathic membranoproliferative glomerulonephritis with a transient glomerular deposition of nephritis-associated plasmin receptor antigen. 2012/04
|
|
80.
|
|
Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study. 2012/04
|
|
81.
|
|
Clinical impact of a combined therapy of The hypothesis that type of species change depends on neutral-pH PD solutions. 2012/04
|
|
82.
|
|
Clinical impact of a combined therapy of The hypothesis that type of species change depends on neutral-pH PD solutions. 2012/04
|
|
83.
|
|
Decreased Extra-renal Urate Excretion is a Common Cause of Hyperuricemia. 2012/04
|
|
84.
|
|
Guidelines and medication compliance. 2012/05
|
|
85.
|
|
Low glomerular density with glomerulomegaly in obesity-related glomerulopathy 2012/05
|
|
86.
|
|
Serum soluble α-Klotho in hemodialysis patients. 2012/05
|
|
87.
|
|
Serum soluble α-klotho in hemodialysis patients. 2012/05
|
|
88.
|
|
Characteristics of spontaneous calcium oscillations in renal tubular epithelial cells. 2012/06
|
|
89.
|
|
Diffuse tubulointerstitial nephritis accompanied by renal crystal formation in an HIV-infected patient undergoing highly active antiretroviral therapy. 2012/06
|
|
90.
|
|
Diffuse tubulointerstitial nephritis associated with ANCA-negative pauci-immune glomerulonephritis. 2012/06
|
|
91.
|
|
Estimation of salt intake from spot urine samples in patients with chronic kidney disease. 2012/06
|
|
92.
|
|
Home systolic blood pressure on the morning of dialysis days has prognostic impact for hypertensive hemodialysis patients 2012/06
|
|
93.
|
|
Morning hypertension determined by self-measurement at home predicts left ventricular hypertrophy in patients undergoing continuous ambulatory peritoneal dialysis. 2012/06
|
|
94.
|
|
Xenotransplanted embryonic kidney provides a niche for endogenous mesenchymal stem cell differentiation into erythropoietin-producing tissue. 2012/06
|
|
95.
|
|
A case of BK virus nephropathy and cytomegalovirus infection concurrent with plasma cell-rich acute rejection. 2012/07
|
|
96.
|
|
Clinicopathological impacts of activated transcription factor c-Jun in peritubular capillary endothelial cells in chronic antibodymediated rejection after kidney transplantation. 2012/07
|
|
97.
|
|
Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. 2012/07
|
|
98.
|
|
Laparoscopic approach for the evaluation of peritoneal injury. 2012/07
|
|
99.
|
|
A lower level of reduced albumin induces serious cardiovascular incidence among peritoneal dialysis. 2012/08
|
|
100.
|
|
A reason for choosing peritoneal dialysis: lessons after the Japan earthquake and the Fukushima nuclear accident. 2012/08
|
|
101.
|
|
ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1 2012/08
|
|
102.
|
|
Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus: ECO (evaluation of cinacalcet HCl outcome) study. 2012/08
|
|
103.
|
|
Effect of combined antihypertensive therapy with losartan/hydrochlorthiazide on uric acid metabolism. 2012/09
|
|
104.
|
|
The effect of metanephros transplantation on blood pressure in anephric rats with induced acute hypotension. 2012/09
|
|
105.
|
|
Do serum hepcidin-25 levels correlate with oxidative stress in patients with chronic kidney disease not receiving dialysis? 2012/10
|
|
106.
|
|
Fungal granulomatous interstitial nephritis presenting as acute kidney injury diagnosed by renal histology including PCR assay. 2012/10
|
|
107.
|
|
Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes 2012/10
|
|
108.
|
|
Successful treatment of monomorphic primary central nervous system post-transplantation lymphoproliferative disorder five years after kidney transplantation. 2012/10
|
|
109.
|
|
The elevation of oxidative stress after the great East Japan earthquake. 2012/10
|
|
110.
|
|
Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathy. 2012/11
|
|
111.
|
|
Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis. 2012/11
|
|
112.
|
|
PGD2-CRTH2 Pathway Promotes Tubulointerstitial Fibrosis. 2012/11
|
|
113.
|
|
Identification of a Xanthinuria Type I Case with Mutations of Xanthine Dehydrogenase in an Afghan Child. 2012/12
|
|
114.
|
|
The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy 2012/12
|
|
115.
|
|
The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes 2013/01/16
|
|
116.
|
|
Sever hyponatremia caused by secondary adrenal insufficiency in a patient with giant pituitary prolactinoma. 2013/02
|
|
117.
|
|
Hereditary renal amyloidosis caused by a heterozygous G654A gelsolin mutation: a report of two cases. 2013/04
|
|
118.
|
|
Detection of dihydropyridine- and voltage-sensitive intracellular Ca(2+) signals in normal human parathyroid cells. 2013/04/16
|
|
119.
|
|
Chest X-ray may serve as a screening examination for coronary artery calcification in dialysis patients. 2013/04/17
|
|
120.
|
|
Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes. 2013/05
|
|
121.
|
|
Acute neutropenia associated with initiation of febuxostat therapy for hyperuricaemia in patients with chronic kidney disease. 2013/06
|
|
122.
|
|
Intensive Antihypertensive Treatment with Angiotensin Receptor Blocker Combined with Hydrocholorthiazide Reduces Urinary Angiotensinogen in Patients with Type 2 Diabetes Mellitus. 2013/06/04
|
|
123.
|
|
Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. 2013/06/18
|
|
124.
|
|
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012. digest version. 2013/08
|
|
125.
|
|
Usefulness of combined application of double-filtration plasmapheresis and twice-daily injections of interferon-beta in hemodialysis patients with hepatitis C virus genotype 1b infection and a high viral load. 2013/09/17
|
|
126.
|
|
Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis. 2013/10
|
|
127.
|
|
Ependymal cells of the mouse brain express urate transporter 1 (URAT1). 2013/10/24
|
|
128.
|
|
Obesity-related glomerulopathy and the nephron complement. 2013/11
|
|
129.
|
|
A nonclassical vitamin D receptor pathway suppresses renal fibrosis. 2013/11/01
|
|
130.
|
|
Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study. 2013/11/20
|
|
131.
|
|
A common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility. 2013/12
|
|
132.
|
|
A Japanese approach for CKD-MBD. 2013/12
|
|
133.
|
|
Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis. 2013/12
|
|
134.
|
|
A common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility. 2013/12/07
|
|
135.
|
|
Mice are unable to endogenously regenerate podocytes during the repair of immunotoxin-induced glomerular injury. 2013/12/08
|
|
136.
|
|
The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study. 2014/01/16
|
|
137.
|
|
The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study. 2014/01/16
|
|
138.
|
|
ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. 2014/01/20
|
|
139.
|
|
Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout. 2014/01/22
|
|
140.
|
|
Risk Factors for Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis: A Retrospective Observational Study. 2014/02
|
|
141.
|
|
Keap1 inhibition attenuates glomerulosclerosis. 2014/02/11
|
|
142.
|
|
Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-LineR during hemodialysis. 2014/02/12
|
|
143.
|
|
Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-LineR during hemodialysis. 2014/02/12
|
|
144.
|
|
Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. 2014/03
|
|
145.
|
|
Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD. 2014/03/07
|
|
146.
|
|
A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease. 2014/03/10
|
|
147.
|
|
A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. 2014/03/18
|
|
148.
|
|
Effects of Irbesartan on Serum Uric Acid Levels in Patients with Hypertension and Diabetes. 2014/05
|
|
149.
|
|
Paracellular Route is the Major Urate Transport Pathway across the Blood-placental Barrier. 2014/05/20
|
|
150.
|
|
Acute vascular rejection during antituberculosis therapy in a kidney transplant patient. 2014/06
|
|
151.
|
|
Comparison of Paricalcitol With Maxacalcitol Injection in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism. 2014/06
|
|
152.
|
|
Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation. 2014/06
|
|
153.
|
|
Successful treatment of BK virus nephropathy using therapeutic drug monitoring of mycophenolic acid. 2014/06
|
|
154.
|
|
Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors. 2014/06/09
|
|
155.
|
|
Common Dysfunctional Variants of ABCG2 Have Stronger Impact on Hyperuricemia Progression than Typical Environmental Risk Factors. 2014/06/09
|
|
156.
|
|
ABCG2 dysfunction increases the risk of renal overload hyperuricemia. 2014/06/18
|
|
157.
|
|
ABCG2 dysfunction increases the risk of renal overload hyperuricemia. 2014/06/18
|
|
158.
|
|
Clinical Feature and ABCG2 Gene Mutation of Gouty Kidneys Diagnosed by Abdominal Ultrasonography. 2014/07
|
|
159.
|
|
Common Variants of cGKII/PRKG2 are not Associated with Gout Susceptibility. 2014/07
|
|
160.
|
|
Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis. 2014/07
|
|
161.
|
|
A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. 2014/08
|
|
162.
|
|
Relationship between Serum Uric Acid Levels and Muscle Strength/volume: a New Insight from a Large-scale Survey. 2014/08
|
|
163.
|
|
A Common Variant of Organic Anion Transporter 4 (OAT4/SLC22A11) Gene is Associated with Renal Underexcretion Type Gout. 2014/09
|
|
164.
|
|
Combined therapy with peritoneal dialysis and hemodialysis: a multicenter retrospective observational cohort study in Japan. 2014/09
|
|
165.
|
|
Dialysate temperature adjustment as an effective treatment for baroreflex failure syndrome in hemodialysis patient. 2014/09
|
|
166.
|
|
Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a Randomized trial. 2014/09
|
|
167.
|
|
Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction. 2014/10
|
|
168.
|
|
New Developments in CKD-MBD. New aspects in phosphate binders 2014/12
|
|
169.
|
|
Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout. 2014/12/18
|
|
170.
|
|
A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis. 2014/12/26
|
|
171.
|
|
Combined therapy using peritoneal dialysis and hemodialysis may increase the indications for peritoneal dialysis in the United State. 2015/01
|
|
172.
|
|
Common Variant of ALPK1 is not Associated with Gout: a Replication Study 2015/01
|
|
173.
|
|
Hydrophilic-interaction Liquid Chromatography-Tandem Mass Spectrometric Determination of Erythrocyte 5-Phosphoribosyl 1-Pyrophosphate in Patients with Hypoxanthine-guanine Phosphoribosyltransferase Deficiency. 2015/01
|
|
174.
|
|
NPT1/SLC17A1 is a Renal Urate Exporter in Humans and Its Common Gain-of-Function Variant Decreases the Risk of Renal Underexcretion Gout. 2015/01
|
|
175.
|
|
The value of ferric citrate, an iron containing phosphate binder, might be different between Japan and United States. 2015/01
|
|
176.
|
|
A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease. 2015/03
|
|
177.
|
|
A Comprehensive Search for Mutations in the PKD1 and PKD2 in Japanese Subjects with Autosomal Dominant Polycystic Kidney Disease. 2015/03
|
|
178.
|
|
Effects of febuxostat on serum urate level in Japanese hyperuricemia patients. 2015/03
|
|
179.
|
|
Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat. 2015/08
|
|
180.
|
|
Serum uric acid and the incidence of CKD and hypertension. 2015/12
|
|
181.
|
|
A Greater Association of Hyperuricemia than of Metabolic Syndrome with the New Incidence of Chronic Kidney Disease. 2016/01
|
|
182.
|
|
A Greater Association of Hyperuricemia than of Metabolic Syndrome with the New Incidence of Chronic Kidney Disease 2016/03
|
|
183.
|
|
Asymptomatic Hyperuricemia. 2016/03
|
|
184.
|
|
Vitamin D receptor activator and prevention of cardiovascular events in hemodialysis patients—rationale and design of the Japan Dialysis Active Vitamin D (J-DAVID) trial. 2016/04/25
|
|
Display 5 items
|
|
Display all(184)
|
